In the
continuation of its efforts to enhance Pakistan’s export competitiveness by
digitalizing cross border trade processes and information requirements, , the
Pakistan Single Window (PSW), in collaboration with the Drug Regulatory
Authority of Pakistan (DRAP), has launched the Digital Certificate of
Pharmaceutical Product (COPP) required on export of pharmaceutical products
by importing countries. In addition to COPP the DRAP Clearance Gateway has also
begun offering electronic Free Sale certificate, Good Manufacturing Practice
(GMP) Certificate and the No Objection Certificate (NOC) for Exports.
This innovative initiative aims to streamline regulatory processes, reduce
delays, and align Pakistan’s pharmaceutical industry with global best
practices.
In line
with best practices, all certificates issued through the PSW platform are
secure, electronically verifiable and embedded with a unique QR code for
instant authentication and verification. The new service eliminates
inefficiencies associated with paper documentation, ensures regulatory
compliance, and enhances transparency and trust in Pakistan’s pharmaceutical
exports—especially in highly regulated markets such as the European Union,
United States, and other global markets.
Exports
remain a cornerstone of Pakistan’s economic development, and strategic efforts
like Uraan Pakistan have been rolled out to support businesses in
cross-border trade. Among key sectors, the pharmaceutical industry has emerged
as a high-potential contributor. In FY 2023–24, Pakistan’s pharmaceutical
exports reached approximately $341 million, reflecting a 3.90% growth
over the previous year.
“We are
proud to introduce the Digital Certificate of Pharmaceutical Product, which
will bring Pakistan’s pharmaceutical industry in line with global best
practices,” said Mr. Aftab Haider, CEO of Pakistan Single Window.
“This initiative significantly enhances the efficiency and transparency of our
regulatory systems and will boost exports by ensuring our products meet the
highest international standards. The initiative is in line with the Prime
Minister’s vision of a Digital Pakistan”
Dr. Obaidullah Malik, CEO of DRAP, emphasized the significance of the
development, stating, “The launch of the Digital
Certificate of Pharmaceutical Product (COPP), Free sale certificate, GMP
Certificate and export NOC
through the DRAP Clearance Gateway reflects our commitment to modernizing
regulatory practices and strengthening trust in Pakistan’s pharmaceutical
sector. This milestone underscores our dedication to ensuring the safe, timely,
and transparent availability of quality medicines, while enabling exporters to
meet international compliance standards with greater efficiency.”
This
development is a key component of Pakistan’s broader strategy to digitalize regulatory
systems, improve operational efficiency, and foster export-led growth in
the pharmaceutical sector. The Digital COPP represents a significant leap
forward in making Pakistan a reliable and competitive player in the global
pharmaceutical market.